Operator of a green construction technology company intended to build a vibrant future for people and the planet. The company designs and manufactures high-performance buildings and green building products that are sustainable, cost-efficient, and resilient in the face of climate change and also significantly reduce construction timelines, enabling clients to obtain reduced build time and construction costs.
Swift Health Systems Inc. is a medical device company based in Irvine, California, that specializes in developing innovative orthodontic solutions. The company's flagship product, INBRACE, is an invisible orthodontic system designed to correct malocclusion by being discreetly positioned behind the teeth. INBRACE employs patented self-guiding technology that utilizes light and continuous forces to gently adjust teeth, minimizing discomfort and reducing the frequency of doctor visits. FDA registered, INBRACE aims to make orthodontic treatment more appealing by addressing common patient concerns and facilitating practice growth for clinicians. The system integrates digital treatment planning, computer modeling, and direct digital manufacturing to offer a scalable and personalized approach to a wide range of orthodontic cases, thereby raising the standard of care in the field.
Divergent Technologies, Inc., based in Los Angeles, California, is focused on transforming the automotive industry through innovative 3D printing technology. Founded in 2014, the company has developed a patented production system that utilizes 3D printed metal connectors, known as Nodes, along with lightweight materials to construct strong and efficient complex structures. This approach eliminates traditional tooling, fostering significant advancements in cost reduction and sustainability within vehicle manufacturing. Divergent's engineering prototype, the Blade, is recognized as the world's first 3D printed supercar, showcasing the potential for radical innovation in automotive design and production. The company has established a strategic partnership with PSA Group to further its mission of empowering a new generation of creative innovators in the automotive sector.
Soli Organic is a company that specializes in the cultivation, packing, and shipping of fresh organic culinary herbs. Founded in 1989 and headquartered in Harrisonburg, Virginia, it operates a production facility in Jefferson, Georgia. Soli Organic offers a diverse range of products, including various herbs such as basil, cilantro, dill, mint, and thyme, as well as herb blends and microgreens. The company provides a year-round supply of these organic herbs to grocery stores, enabling consumers to enjoy locally sourced, flavorful ingredients throughout the year. In addition to its agricultural operations, Soli Organic also offers refrigerated transportation services to ensure efficient delivery. It primarily serves retailers across several states in the southeastern United States, including Georgia, Florida, and North Carolina.
Secure Transfusion Services is a life sciences company that aims to improve the quality and availability of transfusable blood components. The company is dedicated to helping the blood industry modernize and stabilize by enhancing the vital role that nonprofit blood banks play in ensuring the nation's blood supply.
Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices for use in institutional healthcare, home health, and commercial settings.
Interior Define Inc. is a furniture design and manufacturing company based in Chicago, Illinois, founded in 2013. The company specializes in offering customizable furniture products, including sofas, occasional chairs, beds, and dining pieces, allowing customers to tailor their selections by size, fabric, configuration, and other features. By employing a made-to-order production model, Interior Define effectively minimizes inventory costs, enabling it to provide high-quality, personalized furniture at accessible prices. Customers can explore products through an online platform that includes 360-degree views and the option to order free fabric swatches. Additionally, the company enhances the shopping experience with augmented reality tools and offers complimentary white glove delivery, a 365-day return policy, and personalized consultations at its Guideshop locations in major cities such as New York, Chicago, San Francisco, Los Angeles, Boston, and Austin. This combination of digital innovation and physical touchpoints allows Interior Define to deliver a comprehensive custom furniture experience to its clients.
IMV Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies and vaccines for infectious diseases, including COVID-19. Utilizing its proprietary delivery platform, the company targets immune cells within the human body to enhance their ability to attack cancer cells. Its lead candidate, DPX-Survivac, is a targeted T cell therapy that has shown promise in multiple Phase 1 and 1b trials for late-stage ovarian cancer and relapsed/refractory DLBCL. DPX-Survivac is currently undergoing Phase 2 clinical trials across six cancer types and is being evaluated in combination with Keytruda. IMV is also progressing with a DPX-based vaccine for COVID-19, developed in collaboration with experts in infectious diseases, and is working on a vaccine targeting the respiratory syncytial virus strain A. Founded in 2000 and based in Dartmouth, Canada, the company was previously known as Immunovaccine Inc. before rebranding in 2018.
Everstream Analytics is a supply chain risk analytics company that focuses on enhancing the resilience and agility of clients' supply chains. The company offers a platform that tracks supply chain risks and integrates with clients' procurement, logistics, and business continuity systems to provide comprehensive visibility of potential disruptions. By leveraging data science, proprietary intelligence, and a team of multilingual specialists, Everstream monitors global risks and events in real-time, allowing clients to respond swiftly to emerging challenges. The platform also combines risk assessments with business performance indicators, helping organizations develop risk profiles and identify critical hotspots. Through the use of heat maps and actionable insights, Everstream enables companies to manage risks effectively, ensuring business continuity and transforming potential disruptions into competitive advantages.
Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to developing therapies for diseases associated with mitochondrial dysfunction, which includes both rare genetic disorders and common age-related conditions. The company's lead product candidate, Elamipretide, aims to address these health issues, while additional candidates like SBT-20 and SBT-272 are being explored for their potential benefits in stabilizing mitochondrial function and treating neurodegenerative diseases, respectively. Founded in 2006 and based in George Town, Cayman Islands, Stealth BioTherapeutics collaborates with patients and advocacy groups to deepen its understanding of the challenges faced by those with mitochondrial diseases and to raise awareness of their therapeutic programs.
Nogin is an Intelligent Commerce Platform that enables leading brands to keep pace with big retail, drive predictable profitability, exponential growth, and grow rapidly into the future of commerce.
Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, that specializes in the development and commercialization of implantable medical devices aimed at soft tissue restoration and regeneration. Founded in 2014, the company focuses on creating innovative biomaterials and technologies, such as microfluidic biofabrication and electrospinning, to address the needs of patients with sports injuries. Embody's product offerings include collagen-based implants designed for tendon and ligament repairs, specifically targeting conditions like Achilles tendon injuries and rotator cuff tears. The company's mission is to enhance the quality of life for warfighters, athletes, and others suffering from orthopedic injuries by replicating the biological and biomechanical properties of native tissue, ultimately facilitating a return to pre-injury performance.
Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, that specializes in the development and commercialization of implantable medical devices aimed at soft tissue restoration and regeneration. Founded in 2014, the company focuses on creating innovative biomaterials and technologies, such as microfluidic biofabrication and electrospinning, to address the needs of patients with sports injuries. Embody's product offerings include collagen-based implants designed for tendon and ligament repairs, specifically targeting conditions like Achilles tendon injuries and rotator cuff tears. The company's mission is to enhance the quality of life for warfighters, athletes, and others suffering from orthopedic injuries by replicating the biological and biomechanical properties of native tissue, ultimately facilitating a return to pre-injury performance.
Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases, with a particular focus on inherited metabolic disorders. The company's pipeline includes therapies such as CERC-801, CERC-802, and CERC-803, which have completed phase I clinical trials. Additionally, Cerecor is developing CERC-007, an anti-IL-18 monoclonal antibody for autoimmune inflammatory diseases, and CERC-006, a dual mTOR inhibitor for complex lymphatic malformations. Other notable developments include CERC-002 for pediatric-onset Crohn's disease, CERC-913 for mitochondrial disorders, and CERC-005 for rare auto-inflammatory diseases. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions. Founded in 2011 and headquartered in Rockville, Maryland, the company was previously known as Ceregen Corporation before rebranding in March 2011.
Developer of corporate reputation measurement and insights platform intended to help elevate the effectiveness of corporate communications. The company measures and analyzes sentiments using proven data science models and machine learning techniques across industries and geographies and offers corporate reputation advisory services to stakeholders, enabling them to protect business value, improve return on investment and increase their positive impact on society.
LiquiGlide Inc., founded in 2012 and headquartered in Cambridge, Massachusetts, specializes in developing custom-designed liquid-impregnated coatings that create permanently wet slippery surfaces. This innovative technology enables viscous liquids to slide effortlessly, providing a unique and durable solution not available from other companies. LiquiGlide's products cater to a wide range of industries, including manufacturing, oil and gas, processing, aviation, utilities, power generation, water treatment, chemicals, and medical sectors, as well as food and beverage, health and beauty, and household products. The company aims to improve efficiency and reduce waste across various applications by enhancing the flow of liquids.
Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases, with a particular focus on inherited metabolic disorders. The company's pipeline includes therapies such as CERC-801, CERC-802, and CERC-803, which have completed phase I clinical trials. Additionally, Cerecor is developing CERC-007, an anti-IL-18 monoclonal antibody for autoimmune inflammatory diseases, and CERC-006, a dual mTOR inhibitor for complex lymphatic malformations. Other notable developments include CERC-002 for pediatric-onset Crohn's disease, CERC-913 for mitochondrial disorders, and CERC-005 for rare auto-inflammatory diseases. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions. Founded in 2011 and headquartered in Rockville, Maryland, the company was previously known as Ceregen Corporation before rebranding in March 2011.
Launched in 2016, Fingerlix is the brainchild of 4 foodies. Their purpose is to spread Joy through food by easing up cooking and exploration. They believe that Joy stems from spending more time with family and less time in the kitchen. Joy is maximum when they discover something new and different that entices their taste buds. Joy also comes from making healthier, happier food choices that leave us with a feeling of goodness. Through their Ready-to-Cook & Ready-to-Eat food options, they want to be a part of your cooking journey, partnering you, everyday - day after day. And they do their best to make that happen – sourcing choicest ingredients, maintaining extremely high hygiene standards and above all, inspiring your magical touch to transform every dish into ‘Your dish’.
Canary Medical Inc. specializes in the development of medical implant and data management devices that facilitate remote patient monitoring and data collection. The company's primary innovation is the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device designed to gather and process medical data without requiring direct physician intervention. Additionally, Canary Medical creates smart medical devices that provide self-reports on patient activity, recovery, and treatment outcomes, thereby enhancing patient compliance. Established in 2013 and headquartered in Vancouver, Canada, the company has also formed a joint venture with BioScience Managers to launch CHARM Informatics, a platform aimed at collecting and monetizing data from implantable and wearable medical devices.
Alula Holdings, LLC is a smart security company based in Hudson, Wisconsin, that develops and provides a comprehensive security platform tailored for security dealers and installers. Founded in 2018, the company focuses on delivering an integrated solution encompassing security, alarm, video, and automation services for residential and commercial clients. Alula's platform aims to simplify the security experience for independent dealers and their customers, enabling them to manage a variety of applications efficiently. By offering low-cost, Internet-based interactive alarm products and connected property solutions, Alula helps alarm dealers and integrators enhance their service offerings and improve profitability while maintaining brand visibility.
IDbyDNA, Inc. is a company based in Salt Lake City, Utah, founded in 2014, that specializes in metagenomics technologies aimed at the identification of infectious diseases. The company has developed a platform called Explify, which assists laboratories in detecting pathogens through nucleic acid-based identification from various samples. IDbyDNA's offerings include advanced software that utilizes computational biology and artificial intelligence for sequencing-based pathogen detection and characterization. Additionally, the company provides testing services, including respiratory and research services, catering to a diverse clientele that encompasses hospitals, reference labs, clinical research institutions, and the biopharma sector. The overall mission of IDbyDNA is to empower clinicians and researchers with the tools needed to identify any pathogen efficiently, thereby enhancing the capability for comprehensive infectious disease profiling in a streamlined workflow.
Corinth MedTech, Inc. is a medical technology company based in Cupertino, California, that specializes in manufacturing disposable bipolar transurethral and transcervical resectoscopes. Founded in 2011, the company has developed a bipolar transurethral resection system designed for endoscopically controlled tissue removal. This system is specifically intended for male patients suffering from benign prostatic hyperplasia (BPH) and for female patients with conditions such as abnormal uterine bleeding, fibroids, or polyps that necessitate hysteroscopic tissue removal. Corinth MedTech aims to provide effective solutions for these medical conditions through its innovative product offerings.
Sonex Health, LLC, founded in 2014 by physicians from the Mayo Clinic and a business operations expert, is based in Rochester, Minnesota, and specializes in developing micro-invasive surgical devices. The company's flagship product, the SX-One MicroKnife with Meerkat Technology, is designed for treating carpal tunnel syndrome through a novel procedure known as Micro-invasive Carpal Tunnel Release. This innovative approach allows for the surgery to be performed in outpatient settings, significantly enhancing patient recovery times and reducing costs. The SX-One MicroKnife utilizes a micro-incision that is up to five times smaller than traditional methods, which can be closed with a simple adhesive bandage, eliminating the need for stitches. This technique minimizes surgical trauma and enables patients to resume their daily activities more quickly. Sonex Health also offers additional devices such as Stealth MicroGuards and TCL Blade, all aimed at improving surgical outcomes for orthopedic conditions.
Getaround, Inc. operates an online marketplace for peer-to-peer car sharing and local car rentals, allowing users to rent vehicles from people nearby. Founded in 2009 and headquartered in San Francisco, the platform offers a diverse range of vehicles, including convertibles, luxury cars, SUVs, and trucks, available for rent by the hour or day. Getaround's innovative technology, known as Getaround Connect, facilitates a seamless car-sharing experience by enabling users to unlock and access vehicles without needing to meet the car owner or handle physical keys. The service is designed to eliminate the traditional hassles associated with car rentals, such as waiting in line and completing paperwork. Getaround provides users with a $1 million insurance policy and 24/7 roadside assistance, making it a safe option for renters. The company operates in major metropolitan areas across the United States, helping individuals offset car ownership costs while promoting more sustainable transportation options.
Topia specializes in Global Talent Mobility, providing a comprehensive platform that allows companies to manage and engage their employees across the globe. Their solution supports various forms of employee movement, including remote work, business travel, and traditional relocations. By automating the entire talent mobility process, Topia enhances employee experiences and helps organizations align mobility strategies with their broader talent and business objectives. The platform addresses critical aspects such as scenario-based planning, compliance risk management, expat payroll, and reporting, facilitating a seamless experience for both employers and employees. Topia serves a diverse range of reputable brands, empowering them to ensure that the right personnel are located where they are needed most, thereby contributing to a competitive advantage in the marketplace.
Magnolia Medical Technologies, Inc. is a Seattle-based company that specializes in the development and manufacturing of medical devices aimed at enhancing the accuracy of diagnostic blood culture tests. Its flagship product, SteriPath, is a vacuum-assisted blood collection system designed to divert contaminants from the initial blood sample, thereby reducing the incidence of blood culture sample contamination. The company markets its products through distributors across the United States and has built a robust intellectual property portfolio, consisting of over 70 issued patents and more than 50 pending applications. Founded in 2011, Magnolia Medical Technologies is committed to improving diagnostic specimen quality and increasing the accuracy of critical laboratory tests.
Ceribell, Inc. specializes in the design and manufacture of medical devices aimed at acquiring and interpreting electroencephalography (EEG) data for patients with neurological conditions. The company offers the Ceribell EEG System, which includes a versatile EEG headband accommodating various hair types and head sizes, and a compact, battery-operated EEG recorder that delivers clinical-quality data with an on-device display. Ceribell focuses on improving the accessibility and efficiency of EEG technology by developing an FDA-cleared instant EEG system that can be set up by any healthcare provider in just six minutes, eliminating the need for specialized technologists. This system features a unique Brain Stethoscope function that converts brainwaves into sound, allowing for the detection of seizures through auditory means. By facilitating earlier diagnoses and targeted treatments for seizures, including non-convulsive seizures, Ceribell aims to enhance patient outcomes while reducing risks such as mortality and complications. Founded in 2014 and based in Mountain View, California, Ceribell is committed to transforming the diagnosis and management of serious neurological conditions in acute care settings.
Castle Creek Biosciences, Inc. is a gene therapy company based in Exton, Pennsylvania, that specializes in developing personalized gene therapies for rare and serious skin and connective tissue disorders. Founded in 2015, the company utilizes a fibroblast technology platform that extracts fibroblast cells from a patient's own skin. This approach allows for the creation of localized therapies tailored to the unique biology of each individual. By addressing the underlying causes of these conditions, Castle Creek aims to improve the lives of patients facing high unmet medical needs in underserved areas.
OutboundEngine, Inc. is a marketing technology company based in Austin, Texas, specializing in marketing automation software for small and midsize businesses. The company offers the OutboundEngine Platform, a cloud-based solution that automates email marketing, social media posting, and content marketing. It also provides Harmony, a platform designed to unify marketing across franchise and agent networks. OutboundEngine serves a diverse range of sectors, including real estate, finance, insurance, legal, mortgage, and wellness, among others. Founded in 2010 and initially known as Promo Labs LLC, the company rebranded in 2012. With a client base exceeding 10,000 customers, OutboundEngine is recognized for simplifying online marketing, consistently ranking as a top workplace in Austin.
Meditrina, Inc., founded in 2016 and based in San Jose, California, specializes in developing innovative medical devices for tissue removal solutions related to intrauterine pathology. The company provides the Aveta system, designed for healthcare professionals to facilitate hysteroscopic diagnostic and therapeutic procedures, including the removal of polyps and fibroids. In addition to its tissue removal products, Meditrina is also focused on creating fully disposable endoscopes and a comprehensive visualization system intended for use in both office and clinical settings, catering to various medical procedures.
Encore Dermatology is a privately held fully-integrated dermatology company that provides prescription therapies and medical devices to dermatologists. It provides a range of medical dermatology products, treating a number of topical disease states that enable patients to get improved skin care and treatment with ease. Encore Dermatology was established in 2015 and is headquartered in Malvern, Pennsylvania.
Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.
CSA Medical, Inc. develops and manufactures innovative spray cryotherapy medical devices aimed at the destruction of unwanted tissue in various medical fields, including dermatology, gynecology, and general surgery. The company's flagship product, the truFreeze spray cryotherapy device, utilizes cold liquid nitrogen as a cryosurgical tool, allowing for the targeted destruction of tissue while promoting the regeneration of healthy tissue. Additionally, CSA Medical offers the Rapid AV Spray Kit, which enhances the truFreeze system by reducing the time required for liquid nitrogen application. Founded in 1993 and originally known as Crymed Technologies, the company rebranded to CSA Medical in 2006 and is headquartered in Baltimore, Maryland, with a research and development facility located in Lexington, Massachusetts.
MacuLogix, Inc. specializes in the diagnosis, monitoring, and treatment of age-related macular degeneration (AMD), a leading cause of blindness. The company offers the AdaptDx, a fully automated dark adaptometer designed to aid eye care professionals in detecting and tracking AMD at its earliest stages, potentially up to three years before it becomes visible. This early detection capability allows for timely intervention, which can help prevent vision loss. MacuLogix markets its products through distributors in the United States and internationally, as well as online, to ensure accessibility for healthcare providers. Founded in 2008 and based in Harrisburg, Pennsylvania, MacuLogix is committed to leveraging the science of dark adaptation to combat preventable blindness associated with AMD.
New Signature is a cloud-first, full-service Microsoft technology partner that assists businesses of all sizes in addressing their challenges through Microsoft solutions. The company employs a process-driven approach to deliver successful outcomes for complex projects that require creativity, strategic vision, and technical expertise. By conducting rigorous economic analyses, New Signature helps clients make informed investment decisions regarding Microsoft services. The firm provides comprehensive IT support, including planning, design, deployment, customization, and management of Microsoft solutions. Additionally, New Signature focuses on maximizing return on investment by offering tailored user adoption and learning solutions for both business users and IT professionals, thereby promoting trust and credibility through ethical practices.
Ontrak provides specialized health management services to health plans, employers and unions through a network of licensed and company managed health care providers. Catasys’ integrated substance dependence program, OnTrak is designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching and online tools to aid members in their recovery.
Since 2003, we help companies driving digital innovation, with disruptive methodologies. We design new brands, new services and new products, in collaboration with our clients and their partners. We assist large groups, start-ups and SMEs in the conduct of disruption (Disrupt), of digital experience design (Design), and the conduct of growth (Scale). Our approach is different from a digital agency: we are structured as a consultancy, with concrete execution abilities in design and in marketing.
Audacy is a space communications service provider enabling continuous satellite and launch vehicle connectivity from the launchpad to the Moon. Its mission is to deliver anytime, highly operable connectivity that advances humankind to an unparalleled age of space exploration and discovery. The company was founded in 2015 and headquartered in Mountain View, California.
Conventus Orthopaedics provides a range of orthopedic and sports medicine services. The physicians specialize in orthopedic surgery, reconstructive surgery, spine surgery, joint replacement, sports medicine, physical therapy, and operative care of fractures, arthritis, strains, sprains, and sports-related injuries. Conventus was formed by a team of medical professionals with the sole purpose of creating less invasive ways to treat challenging periarticular fractures. By leveraging advanced nitinol technology, the Conventus team has developed a platform technology that provides robust fixation and creates reliable repairs. The company was incorporated in 2009 and is based in Maple Grove, Minnesota.
IntelePeer is a provider of cloud-based communication solutions, focusing on enhancing business communications through its CPaaS-based platform. The company offers a range of services, including enterprise voice, SIP trunking, and cloud contact center solutions. By integrating AI and analytics, IntelePeer's platform enables businesses to improve customer interactions and drive revenue growth. Its omnichannel approach allows for seamless communication across various channels, facilitating better decision-making and customer satisfaction. The platform is designed to work effortlessly with existing business systems, making it a versatile choice for enterprises looking to enhance their communication capabilities.
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, focused on developing non-invasive treatment solutions for nasal breathing disorders. Founded in 2011, the company specializes in therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of conditions such as nasal obstruction and chronic rhinitis. Aerin Medical offers procedures and devices, including the VivAer procedure and the RhinAer procedure, along with their corresponding styluses, which allow ENT physicians to treat nasal airway conditions in an office setting under local anesthesia. These innovative solutions aim to improve patient outcomes by providing safe, quick, and effective relief from chronic nasal symptoms while minimizing downtime.
Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing proprietary therapeutics for chronic diseases through its innovative ProNeura long-term drug delivery platform. The company's key product, Probuphine, is the first slow-release implant formulation of buprenorphine, designed to provide stable medication levels for up to six months, thereby enhancing patient compliance in the treatment of opioid dependence. Titan also develops ProNeura-Ropinirole, an implant for delivering ropinirole to treat Parkinson's disease, and a similar implant for managing hypothyroidism. The ProNeura technology holds promise for addressing various chronic conditions by ensuring consistent drug delivery, which can improve patient outcomes. In December 2012, Titan entered a licensing agreement granting Braeburn Pharmaceuticals exclusive commercialization rights to Probuphine in the U.S. and Canada, receiving significant financial incentives tied to regulatory approvals and sales milestones. Additionally, Titan receives royalties from the sales of Fanapt, an atypical antipsychotic, further supporting its development efforts.
PebblePost, Inc. is a New York-based company that operates a digital-to-direct mail marketing platform. Established in 2014, PebblePost specializes in transforming online consumer behavior into targeted direct mail campaigns. By leveraging online interest and intent data, the company sends personalized direct mail that aims to activate purchasing decisions and enhance conversion rates. PebblePost is known for its innovation in Programmatic Direct Mail, which utilizes advanced targeting and algorithmic optimization techniques. The platform integrates various marketing functions, including segmentation, campaign management, production, analytics, and optimization, allowing brands to effectively engage consumers through tailored media impressions delivered to their homes.
IgnitionOne, Inc. develops cloud-based digital marketing software solutions designed for online marketers globally. The company offers a comprehensive Marketing Hub Data Management Platform that consolidates customer information across various channels and touchpoints, alongside a Digital Marketing Dashboard that provides insights into audience activities and campaign performance. Its Digital Marketing Suite includes analytics tools and management solutions for creative assets and search optimization. Additionally, IgnitionOne specializes in website personalization and email optimization. Founded in 2004 and headquartered in New York, IgnitionOne aims to empower enterprise marketers by providing a unified platform that leverages customer data for effective omnichannel targeting and personalization. The company was previously known as SearchIgnite, Inc. until its rebranding in 2011 and is a former subsidiary of 360i LLC.
Receptiv is a mobile video advertising platform that connects brands with receptive users during significant moments to enhance advertising performance. Established in 2011 as MediaBrix and rebranded in 2017, Receptiv uses emotional targeting and audience intelligence to optimize ad delivery. Its first-party data management platform, Motiv, leverages insights from 150 million device IDs to create contextualized brand engagements. Receptiv operates through both programmatic and managed services, facilitating interactions across over 1,300 premium apps and generating 500 million key moments monthly. The company, based in New York, serves a diverse range of prominent brands, including Mars, Coca-Cola, and Microsoft, and is backed by investors such as Edison Partners and Revel Partners. As of 2018, Receptiv operates as a subsidiary of Verve Wireless, Inc.
ScoreBig, Inc. operates an online marketplace that focuses on providing consumers with discounted tickets to live events, including sports games, concerts, and theater performances. Established in 2009 and based in Hollywood, California, the company offers a unique opaque sales channel, allowing fans to save up to 60% on ticket purchases. By selling a limited number of tickets per event, ScoreBig helps venue operators and sports teams manage unsold inventory without undermining their regular pricing strategies. This approach enables consumers to access a wide range of tickets, from premium seats to more affordable options, while also supporting event organizers in maximizing revenue. As of November 2016, ScoreBig operates as a subsidiary of Ticket Software, LLC.
Avalanche Technology, Inc. develops and markets a non-volatile spin transfer torque magnetic random access memory device. It offers its device for applications in mobile (consumer wearable devices), Internet of Things, enterprise storage, computing, networking, telecommunication, automotive, and other industries. Avalanche Technology, Inc. was formerly known as Yadav Technology Inc. The company was incorporated in 2006 and is based in Fremont, California.
Nomi's Marketing Platform helps businesses optimize their brick and mortar stores just like their website.
Digital Signal, founded in 2001 and based in Chantilly, Virginia, specializes in three-dimensional long-range facial recognition technology tailored for both government and commercial clients. The company develops LIDAR-based biometric solutions designed to identify non-cooperative individuals and detect faces in crowded environments. Its technology offers comprehensive identity intelligence, encompassing enrollment, monitoring, and identity analytics. By leveraging the advanced capabilities of 3D facial scanning, Digital Signal's solutions can accurately identify subjects in motion or at various angles, even when wearing sunglasses, which enhances surveillance efficiency and effectiveness. The company also provides customized applications to meet specific customer requirements.
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.
Bridge2 Solutions is the leading innovator in the world of incentive, consumer and performance rewards. Bridging Performance Improvement agencies with best-in-class retail and service organizations to create a new business model for reward fulfillment that re-defines the industry.
Medsphere Systems Corporation specializes in healthcare information technology solutions, primarily through its open-source electronic health record platform, OpenVista. This platform encompasses a wide range of functionalities, including clinical, financial, and patient accounting systems, as well as modules for laboratory, pharmacy, radiology, nutrition, and multi-disciplinary treatment planning. In addition to its software offerings, Medsphere provides a variety of services such as implementation, training, system and software engineering, project management, and IT infrastructure support. The company caters to a diverse clientele, including critical access hospitals, acute care facilities, behavioral health centers, and physician practices. Founded in 2002 and headquartered in Carlsbad, California, Medsphere aims to enhance patient care and streamline clinical workflows through its comprehensive healthcare technology solutions.
SilkRoad Technology, Inc. is a global provider of cloud-based talent management solutions, offering a comprehensive suite of services designed to help organizations find, attract, develop, and retain talent. Their offerings include the SilkRoad Suite Start for Talent Acquisition, SilkRoad Recruiting for utilizing social channels in recruitment, and SilkRoad Onboarding for employee onboarding. Additionally, the company provides SilkRoad HRMS for managing employee data and SilkRoad Performance for employee performance management. With a focus on user engagement and collaboration, the SilkRoad Life Suite integrates Talent Acquisition, Talent Development, and HRMS solutions through a user-friendly Talent Portal. SilkRoad Technology serves various industries, including financial services, healthcare, education, manufacturing, professional services, and retail. Founded in 2003 and headquartered in Chicago, Illinois, the company has multiple locations across the United States and internationally, including offices in Canada, Australia, the United Kingdom, France, Denmark, Japan, and the Philippines.
SavingStar, Inc. is a cash back platform that provides rewards for grocery and online shopping. Launched in 2010 and based in Waltham, Massachusetts, the platform allows users to earn cash back by linking offers to their supermarket and drugstore loyalty cards or by submitting receipts. Users can earn double cash back when shopping at various online retailers. The service is designed to streamline the shopping experience by eliminating the need for paper coupons, as offers are automatically validated and credited to users' accounts. Additionally, SavingStar enables brands to promote specific products through incentives and rewards that encourage customer engagement. The company was previously known as SaveWave Inc. before rebranding in 2011 and operates as a subsidiary of Quotient Technology Inc.
ScoreBig, Inc. operates an online marketplace that focuses on providing consumers with discounted tickets to live events, including sports games, concerts, and theater performances. Established in 2009 and based in Hollywood, California, the company offers a unique opaque sales channel, allowing fans to save up to 60% on ticket purchases. By selling a limited number of tickets per event, ScoreBig helps venue operators and sports teams manage unsold inventory without undermining their regular pricing strategies. This approach enables consumers to access a wide range of tickets, from premium seats to more affordable options, while also supporting event organizers in maximizing revenue. As of November 2016, ScoreBig operates as a subsidiary of Ticket Software, LLC.
NinePoint Medical, Inc. is a medical device company based in Bedford, Massachusetts, that specializes in optical coherence tomography (OCT) imaging systems for assessing human tissue microstructure. The company's flagship product, the NvisionVLE Imaging System, provides real-time volumetric images of the esophagus and bile duct, enabling healthcare professionals across various specialties, including gastroenterology and pulmonology, to conduct advanced imaging procedures. This technology allows for high-resolution, cross-sectional views that facilitate accurate diagnoses and effective therapies during medical procedures. NinePoint aims to enhance the efficiency of patient care by integrating access to imaging, diagnosis, and treatment in a single procedure, ultimately improving patient outcomes and reducing healthcare costs. The company markets its products through distributors both domestically and internationally. Established in 2008, NinePoint Medical was formerly known as Convergence Devices, Inc. and underwent a name change in 2009.
Palatin Technologies, Inc. is a biopharmaceutical company focused on developing targeted receptor-specific therapeutics to address various medical conditions with significant unmet needs. The company's lead product, Vyleesi, is a melanocortin receptor agonist designed to treat premenopausal women with acquired, generalized hypoactive sexual desire disorder. In addition, Palatin is advancing several other drug candidates, including oral PL8177, a selective melanocortin receptor 1 agonist aimed at treating inflammatory bowel diseases, and systemic PL8177 for non-infectious uveitis and COVID-19. The company is also developing PL9643 for anti-inflammatory ocular conditions, particularly dry eye disease, and PL3994, a natriuretic peptide receptor-A agonist for cardiovascular issues. Furthermore, PL5028 is being explored as a treatment for cardiovascular and fibrotic diseases. Founded in 1986 and based in Cranbury, New Jersey, Palatin Technologies is committed to creating innovative therapies that address critical health challenges.
Interleukin Genetics, Inc. is a company that specializes in personalized health through genetic testing. It develops and sells genetic tests aimed at helping individuals improve their health and wellness. The company focuses on two main areas: providing genetic test products directly to consumers and through sales partners, and conducting research and development to create genetic tests in collaboration with partners for medical and dental applications. By offering personalized insights related to chronic diseases and health conditions, Interleukin Genetics aims to empower individuals with the information needed to make informed decisions about their health, including specific dietary and exercise recommendations. This approach aligns with their mission of enhancing preventive health measures and improving overall health outcomes.
ZetrOZ is revolutionizing the ultrasound industry by introducing proprietary generator technology that is more efficient, more portable, and more economically viable than any ultrasound generator presently available.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.
Argos Therapeutics, Inc. was a biotechnology company based in Durham, North Carolina, focused on developing individualized immunotherapies for cancer, infectious diseases, and autoimmune disorders. Utilizing its proprietary Arcelis technology platform, the company aimed to create personalized treatments, including rocapuldencel-T, which was undergoing Phase III clinical trials for metastatic renal cell carcinoma, and AGS-004, in Phase II trials for human immunodeficiency virus. Argos also explored therapies for transplant rejection and autoimmune diseases, with products in various stages of development targeting conditions such as lupus and other inflammatory disorders. Founded in 1997, the company was previously known as Merix Bioscience, Inc. However, Argos Therapeutics ceased operations and filed for Chapter 7 bankruptcy on September 24, 2019.
IntegenX Inc. specializes in developing human DNA identification solutions, utilizing advanced fluidics, optics, and biochemistry to create automated systems for DNA-based human identity testing. The company’s flagship product, the RapidHIT System, provides a sample-to-answer solution for STR-based human identification, generating standardized DNA profiles from buccal swabs and other samples. Additionally, IntegenX offers the RapidHIT GlobalFiler Express Kit for processing various swab types and crime scene samples, as well as RapidHIT PowerPlex 16 HS kits. The company distributes its products through various international channels, including markets in Europe and Asia. Founded in 2003 and based in Pleasanton, California, IntegenX was previously known as Microchip Biotechnologies, Inc. and rebranded in 2010. As of 2018, it operates as a subsidiary of Thermo Fisher Scientific Inc.
SpringCM Inc. offers a cloud-based document and contract management platform that enhances organizational workflows and collaboration on documents. The platform streamlines the contract lifecycle, facilitating processes from creation to negotiation, approvals, signatures, archiving, and renewals. SpringCM also provides a digital asset management system that automates content management, sharing, and collaboration, as well as tools for managing sales quotes and proposals. Its software is deployed as a Software-as-a-Service solution, complemented by a mobile application, and supports various sectors, including legal, IT, operations, sales, and finance. The company also provides consulting, training, and support services. Founded in 2005 and headquartered in Chicago, Illinois, SpringCM operates as a subsidiary of DocuSign, Inc., following its acquisition in 2018. The company has established a strategic partnership with Salesforce to enhance its offerings.
Founded in 1999, Mblox is a leading provider of mobile messaging solutions, specializing in Application-to-Person (A2P) messaging. The company maintains over 100 direct carrier relationships, which enables it to process approximately 7 billion mobile messages annually for more than 4,000 customers across various sectors, including financial services, government, transportation, logistics, retail, and advertising. Mblox's cloud-based platform is designed to accommodate businesses of all sizes, from startups to large multinational corporations. The company is known for its reliable service and offers 24/7 email support from an in-house team of experts, along with various support packages tailored to meet individual business needs.
GenePeeks, Inc. is a genetic information company focused on helping families mitigate the risk of heritable diseases. Established in 2009 and based in New York, the company has developed a proprietary software platform that utilizes Next-Generation sequencing data to simulate the genetic recombination that occurs during human reproduction. By digitally weaving together the DNA of prospective parents, GenePeeks' technology generates analytic targets that represent tens of thousands of "virtual genomes," offering insights into the potential genetic profile of future children. This approach enables the identification of disease risks that are not detectable through existing pre-conception screening methods, providing valuable genetic insight for healthcare professionals and prospective parents.
Social Intelligence Corp. is a company based in Santa Barbara, California, that specializes in providing software-as-a-service (SaaS) solutions for social media data analysis and investigations. Founded in 2010, it caters to both commercial and government organizations by offering tools that facilitate background screenings, insurance claims investigations, and corporate due diligence. The company leverages publicly available online information while ensuring compliance with legal standards, including the Fair Credit Reporting Act. Its product suite includes predictive scoring algorithms, investigative reports, and various analytics tools designed to enhance safety and reduce costs for clients. Social Intelligence is committed to maintaining privacy and promoting responsible use of data, employing a team with extensive experience across relevant industries.
AccuVein Inc. is a manufacturer of vein visualization solutions aimed at improving vascular access for healthcare professionals. Founded in 2006 and based in Medford, New York, the company specializes in portable, non-contact devices that illuminate peripheral veins, enabling practitioners to see a detailed map of veins beneath the skin. Its flagship product, the AV400, is designed to enhance procedures such as blood draws, IV infusions, and cosmetic injections by allowing accurate vein identification and access. AccuVein's offerings also include various hands-free and wheeled solutions that cater to different medical settings, including surgery centers, imaging centers, and long-term care facilities. The company distributes its products through a network of sales representatives and distributors both in the United States and internationally.
Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.
Overture Networks, Inc. specializes in providing virtualization solutions and high-speed carrier Ethernet services to service providers. The company offers a range of products designed to facilitate cost-effective service delivery and revenue generation. Key offerings include the Overture Orchestrator for operational efficiency, Overture Analytics for actionable intelligence, and an open-source SDN controller to manage network configurations. Its hardware solutions, such as the Overture 65, Overture 1400, and Overture 6500, cater to various needs, from Ethernet access devices to carrier-grade aggregation and switching platforms. These products enable seamless integration of packet-switched and circuit-switched technologies, facilitating service delivery over copper, fiber, or optical transport. Founded in 2000 and headquartered in Morrisville, North Carolina, Overture Networks also has development offices in Westford, Massachusetts, and Bangalore, India. The company operates as a subsidiary of ADVA Optical Networking SE.
Valore operates an online marketplace designed for college students to buy, sell, and rent textbooks and other educational resources. Based in San Diego, ValoreBooks.com connects students with over 14,000 booksellers nationwide, offering textbooks at discounts of up to 90 percent off the list price, significantly lower than traditional campus bookstores. In addition to its extensive selection of affordable textbooks, Valore provides interactive tools and advice on college costs and student loans. The company is recognized for its commitment to customer service and for giving back to students, enhancing the overall educational experience.
Radisphere National Radiology Group, Inc. specializes in providing radiology delivery solutions to hospitals and health systems, operating in over 28 states with more than 100 clients. The company offers cloud-based technology solutions, including RadVision and RadPerform, which enhance transparency in performance, quality data analysis, and benchmarking across systems. These tools help manage performance, eliminate clinical variation, and reduce labor costs through effective capacity planning and resource allocation. Radisphere's services also facilitate real-time decision support and timely communication of critical findings, while providing access to national teleradiology networks for continuous coverage. By centralizing radiology management, Radisphere enables health systems to improve care quality and reduce costs, establishing measurable standards for diagnostic accuracy and patient care. Founded in 2001 and based in Beachwood, Ohio, Radisphere was previously known as Franklin & Seidelmann, LLC before its rebranding in 2010.
Private Equity Round in 2009
Grab Media (formerly Grab Networks) is a leading premium video distribution company that connects premium video content from a wide collection of professional sources and brand-name advertisers to ideal viewers. Marketers rely on Grab Media to position their message in front of large-scale, engaged audiences, so they can focus on brand promotion.
Tagged.com was launched in 2004, and is an explosively growing social-networking portal developed specifically for teens aged 13 through 19. Emerging as the premier brand in the lucrative teen demographic, Tagged.com is rapidly becoming the number one teen site on the web.
Revance Therapeutics, Inc. is a biotechnology company focused on the development, manufacture, and commercialization of neuromodulators for aesthetic and therapeutic uses. The company’s lead product, DaxibotulinumtoxinA for injection (DAXI), is undergoing clinical trials for various conditions, including glabellar lines, cervical dystonia, adult upper limb spasticity, and chronic migraine. In addition, DAXI is being evaluated for cosmetic applications such as forehead lines and lateral canthal lines. Revance is also developing DaxibotulinumtoxinA Topical for both therapeutic and aesthetic purposes, and it is working on a biosimilar to BOTOX in collaboration with Mylan. Founded in 1999 and originally known as Essentia Biosystems, the company is headquartered in Newark, California.
Ambit Biosciences is a privately-held biopharmaceutical company dedicated to the discovery and development of small molecule kinase inhibitors aimed at treating cancer, inflammatory diseases, and other conditions. The company's lead compound, AC220, is a selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various indications. The clinical pipeline also includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. In addition, Ambit has several preclinical candidates, including CEP-32496, a BRAF inhibitor that has been licensed to Cephalon. Through its innovative research, Ambit aims to improve treatment outcomes for patients suffering from cancer.
COPAN Systems, Inc. specializes in providing storage solutions that focus on managing and protecting long-term persistent data. Founded in 2002 and headquartered in Longmont, Colorado, the company offers a range of products including virtual tape libraries for backup and disaster recovery, as well as archive solutions designed to retain digital assets with efficient file-level storage and retrieval. Its offerings encompass data protection, tiered storage, and energy-efficient power and cooling systems. COPAN Systems serves a diverse clientele across various sectors, including education, finance, government, healthcare, technology, media, and service providers.
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic diseases that require long-term treatment. The company is known for its innovative Medici Drug Delivery System, which utilizes subcutaneous delivery methods to provide steady dosing of therapeutic agents, particularly for conditions such as type 2 diabetes and obesity. Its flagship product, ITCA 650, is currently in a phase 3 clinical program aimed at improving treatment outcomes for diabetes patients through a unique delivery mechanism. In addition to diabetes, Intarcia is engaged in research and development for therapies targeting autoimmune disorders and other chronic conditions. Founded in 1995 and headquartered in Boston, Massachusetts, Intarcia also has a manufacturing facility in Hayward, California, and a research center in Durham, North Carolina.